The United States is a key market for India’s pharmaceutical exports, with India supplying around 40 per cent of all generic ...

Indian pharmaceutical stocks fell 4.4% on Friday, wiping out gains from the previous session, after U.S. President Donald ...

Nifty Pharma took a beating on Friday declining over four per cent, after Donald Trump hinted at a separate tariff for ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

Indian shares tumbled after President Donald Trump’s comments that the US is still considering tariffs on pharmaceutical ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

US President says India imposes 52% tariff on American imports and engages in currency manipulation and non-tariff barriers ...

US pharmaceutical industry faces uncertainty with potential tariffs, impacting companies and healthcare costs, awaiting ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

India expects minimal price changes for its pharma exports under new US tariffs, as punitive measures haven’t hit the sector ...

India emerges stronger in the US-India reciprocal tariffs scenario, negotiating favorable trade agreements and protecting ...

Policymakers should establish dedicated clinical research units within premier institutions like Aiims and NIPERs, regulatory ...